Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member printed grouped question UIN question first answered answering member label attachment file name title
tabling member	label

Search

1666274

registered interest
date	19/10/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Genetics: Screening
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government what assessment they have made of Nolan and Ormondroyd’s systematic review published on 30 March in Clinical Genetics, setting out the consequences for consumers and health services of direct-to-consumer genetic testing and how it relates to equitable healthcare; and what assessment they have made of the regulation of direct-to-consumer genetic testing.
tabling member printed	Baroness Bennett of Manor Castle
uin	HL10676
answer	answer is ministerial correction date of answer 25/10/2023 answer text <p>Whilst no specific assessment has been made of Nolan and Ormondroyd’s systematic review published in March 2023 or Emma Wilkinson’s article published in October 2022, the Government recognises both the opportunities and risks raised by direct-to-consumer genomic tests and is committed to ensuring effective and proportionate regulation.</p><p>In consideration of the regulation of direct-to-consumer genetic and health testing, the Medicines and Healthcare products Regulatory Agency is working to develop a robust, world-leading regulatory regime for such medical devices that prioritises patient safety.</p> answering member printed Lord Markham grouped question UIN HL10677 question first answered 25/10/2023 11:20:51 answering member 4948 label Biography information for Lord Markham
tabling member	4719 label Biography information for Baroness Bennett of Manor Castle

1666275

registered interest
date	19/10/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Genetics: Screening
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government what assessment they have made of Emma Wilkinson’s article published in October 2022 in The BMJ on the impact of direct-to-consumer testing on the public and the NHS, and of how this relates to the regulation of direct-to-consumer health testing.
tabling member printed	Baroness Bennett of Manor Castle
uin	HL10677
answer	answer is ministerial correction date of answer 25/10/2023 answer text <p>Whilst no specific assessment has been made of Nolan and Ormondroyd’s systematic review published in March 2023 or Emma Wilkinson’s article published in October 2022, the Government recognises both the opportunities and risks raised by direct-to-consumer genomic tests and is committed to ensuring effective and proportionate regulation.</p><p>In consideration of the regulation of direct-to-consumer genetic and health testing, the Medicines and Healthcare products Regulatory Agency is working to develop a robust, world-leading regulatory regime for such medical devices that prioritises patient safety.</p> answering member printed Lord Markham grouped question UIN HL10676 question first answered 25/10/2023 11:20:51 answering member 4948 label Biography information for Lord Markham
tabling member	4719 label Biography information for Baroness Bennett of Manor Castle

1664770

registered interest
date	16/10/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Antimicrobials: Drug Resistance
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government what progress they have made towards introducing the recording of antimicrobial resistance as a cause of death on death certificates.
tabling member printed	Baroness Bennett of Manor Castle
uin	HL10490
answer	answer is ministerial correction date of answer 25/10/2023 answer text <p>Medical practitioners are expected to state the cause of death on death certificates to the best of their knowledge and belief, including where a resistant infection was a contributory factor. Consistently citing antimicrobial resistance (AMR) as a cause of death on the Medical Certificate of Cause of Death (MCCD) could provide better data on the scale and impact of AMR and improve public awareness of the issue.</p><p>In November 2022, as part of the National Medical Examiner’s “Good Practice Series”, the Royal College of Pathologists published a paper to help medical examiner offices align with the UK AMR National Action Plan, and support surveillance of antimicrobial resistance. The paper asks medical examiners to encourage and educate those writing MCCDs to accurately record the organism responsible for the infection, whether it was resistant to microbial therapy, and whether the infection was hospital- or community-associated, where this is known. A copy of the paper is attached.</p> answering member printed Lord Markham question first answered 25/10/2023 11:17:39 answering member 4948 label Biography information for Lord Markham attachment 1 file name Good-Practice-Series-Recording-antimicrobial-resistance-on-the-Medical-Certificate-of-Cause-of-DeathFinal (1).pdf title Good Practice Series
tabling member	4719 label Biography information for Baroness Bennett of Manor Castle